These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 9575405)

  • 1. [The delivery of loperamide to the brain by using polybutyl cyanoacrylate nanoparticles].
    Aliautdin RN; Petrov VE; Langer K; Berthold A; Kreuter J; Kharkevich DA
    Eksp Klin Farmakol; 1998; 61(1):17-20. PubMed ID: 9575405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delivery of loperamide across the blood-brain barrier with polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
    Alyautdin RN; Petrov VE; Langer K; Berthold A; Kharkevich DA; Kreuter J
    Pharm Res; 1997 Mar; 14(3):325-8. PubMed ID: 9098875
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug delivery to the brain using surfactant-coated poly(lactide-co-glycolide) nanoparticles: influence of the formulation parameters.
    Gelperina S; Maksimenko O; Khalansky A; Vanchugova L; Shipulo E; Abbasova K; Berdiev R; Wohlfart S; Chepurnova N; Kreuter J
    Eur J Pharm Biopharm; 2010 Feb; 74(2):157-63. PubMed ID: 19755158
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of particle size on transport of methotrexate across blood brain barrier by polysorbate 80-coated polybutylcyanoacrylate nanoparticles.
    Gao K; Jiang X
    Int J Pharm; 2006 Mar; 310(1-2):213-9. PubMed ID: 16426779
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Covalent linkage of apolipoprotein e to albumin nanoparticles strongly enhances drug transport into the brain.
    Michaelis K; Hoffmann MM; Dreis S; Herbert E; Alyautdin RN; Michaelis M; Kreuter J; Langer K
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1246-53. PubMed ID: 16554356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transferrin- and transferrin-receptor-antibody-modified nanoparticles enable drug delivery across the blood-brain barrier (BBB).
    Ulbrich K; Hekmatara T; Herbert E; Kreuter J
    Eur J Pharm Biopharm; 2009 Feb; 71(2):251-6. PubMed ID: 18805484
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of tacrine into the brain with polysorbate 80-coated poly(n-butylcyanoacrylate) nanoparticles.
    Wilson B; Samanta MK; Santhi K; Kumar KP; Paramakrishnan N; Suresh B
    Eur J Pharm Biopharm; 2008 Sep; 70(1):75-84. PubMed ID: 18472255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Brain targeting of nerve growth factor using poly(butyl cyanoacrylate) nanoparticles.
    Kurakhmaeva KB; Djindjikhashvili IA; Petrov VE; Balabanyan VU; Voronina TA; Trofimov SS; Kreuter J; Gelperina S; Begley D; Alyautdin RN
    J Drug Target; 2009 Sep; 17(8):564-74. PubMed ID: 19694610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Covalent attachment of apolipoprotein A-I and apolipoprotein B-100 to albumin nanoparticles enables drug transport into the brain.
    Kreuter J; Hekmatara T; Dreis S; Vogel T; Gelperina S; Langer K
    J Control Release; 2007 Mar; 118(1):54-8. PubMed ID: 17250920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of surface modification of PLGA-PEG-PLGA nanoparticles on loperamide delivery efficiency across the blood-brain barrier.
    Chen YC; Hsieh WY; Lee WF; Zeng DT
    J Biomater Appl; 2013 Mar; 27(7):909-22. PubMed ID: 22207601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Drug delivery to the brain with nanoparticles].
    Aliautdin RN; Kreuter J; Kharkevich DA
    Eksp Klin Farmakol; 2003; 66(2):65-8. PubMed ID: 12962052
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics of transport of doxorubicin bound to nanoparticles across the blood-brain barrier.
    Wohlfart S; Khalansky AS; Gelperina S; Begley D; Kreuter J
    J Control Release; 2011 Aug; 154(1):103-7. PubMed ID: 21616104
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticle-mediated delivery of neurotoxin-II to the brain with intranasal administration: an effective strategy to improve antinociceptive activity of neurotoxin.
    Ruan Y; Yao L; Zhang B; Zhang S; Guo J
    Drug Dev Ind Pharm; 2012 Jan; 38(1):123-8. PubMed ID: 21721852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vitro release performance and analgesic activity of endomorphin-1 loaded nanoparticles.
    Liu H; Ni J; Wang R
    Pharmazie; 2006 May; 61(5):450-2. PubMed ID: 16724544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The first step into the brain: uptake of NIO-PBCA nanoparticles by endothelial cells in vitro and in vivo, and direct evidence for their blood-brain barrier permeation.
    Weiss CK; Kohnle MV; Landfester K; Hauk T; Fischer D; Schmitz-Wienke J; Mailänder V
    ChemMedChem; 2008 Sep; 3(9):1395-403. PubMed ID: 18613205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transport of Poly(n-butylcyano-acrylate) nanoparticles across the blood-brain barrier in vitro and their influence on barrier integrity.
    Rempe R; Cramer S; Hüwel S; Galla HJ
    Biochem Biophys Res Commun; 2011 Mar; 406(1):64-9. PubMed ID: 21295549
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant entry of tubocurarine into the brain of rats by adsorption to polysorbate 80-coated polybutylcyanoacrylate nanoparticles: an in situ brain perfusion study.
    Alyautdin RN; Tezikov EB; Ramge P; Kharkevich DA; Begley DJ; Kreuter J
    J Microencapsul; 1998; 15(1):67-74. PubMed ID: 9463808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential in vivo sensitivity to inhibition of P-glycoprotein located in lymphocytes, testes, and the blood-brain barrier.
    Choo EF; Kurnik D; Muszkat M; Ohkubo T; Shay SD; Higginbotham JN; Glaeser H; Kim RB; Wood AJ; Wilkinson GR
    J Pharmacol Exp Ther; 2006 Jun; 317(3):1012-8. PubMed ID: 16537797
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interaction of poly(butylcyanoacrylate) nanoparticles with the blood-brain barrier in vivo and in vitro.
    Alyaudtin RN; Reichel A; Löbenberg R; Ramge P; Kreuter J; Begley DJ
    J Drug Target; 2001 Jun; 9(3):209-21. PubMed ID: 11697206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Apolipoprotein-mediated transport of nanoparticle-bound drugs across the blood-brain barrier.
    Kreuter J; Shamenkov D; Petrov V; Ramge P; Cychutek K; Koch-Brandt C; Alyautdin R
    J Drug Target; 2002 Jun; 10(4):317-25. PubMed ID: 12164380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.